Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DNA X, Inc.SONM · Entity 8261 | Director · Chief Executive Officer | May 22, 2019 | May 23, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DNA X, Inc.
Report date May 22, 2019 · Filed May 23, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 504,250 |
Reported balance
After 2019-05-22 transaction · row 1
1 source rowRow 1 · 2019-05-22 · Sale · Disposed 30,000 · Balance 504,250 F1: These shares were sold by the reporting person as a selling stockholder pursuant to an underwritten public offering by the Issuer. The reported sale price reflects the price at which the reporting person sold shares to the underwriters. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold by the reporting person as a selling stockholder pursuant to an underwritten public offering by the Issuer. The reported sale price reflects the price at which the reporting person sold shares to the underwriters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2019 Filed May 23, 2019 22:35 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 30,000 | $10.23 | $306,900.00 |
DisclosureSEC source: 0001209191-19-032467 · doc4.xml · nonDerivative · entry 1 Plaschke Robert · CIK 0001774816 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,250 F1 · price: These shares were sold by the reporting person as a selling stockholder pursuant to an underwritten public offering by the Issuer. The reported sale price reflects the price at which the reporting person sold shares to the underwriters. Read SEC document |
| May 13, 2019 Filed May 15, 2019 00:16 UTC | DNA X, Inc. SONM · Entity 8261 | Tax withholdingCommon Stock | 172,439 | $11.00 | $1,896,829.00 |
DisclosureSEC source: 0001209191-19-029813 · doc4.xml · nonDerivative · entry 2 Plaschke Robert · CIK 0001774816 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,250 F1 · shares: Represents shares withheld by the Issuer to satisfy tax obligations associated with the grant of the fully vested restricted stock award of 383,197 shares to the Reporting Person. Read SEC document |
| May 13, 2019 Filed May 15, 2019 00:16 UTC | DNA X, Inc. SONM · Entity 8261 | GrantCommon Stock | 383,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029813 · doc4.xml · nonDerivative · entry 1 Plaschke Robert · CIK 0001774816 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706,689 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.